Search by Drug Name or NDC

    NDC 00456-3205-60 Namenda 5 mg/1 Details

    Namenda 5 mg/1

    Namenda is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is MEMANTINE HYDROCHLORIDE.

    Product Information

    NDC 00456-3205
    Product ID 0456-3205_8bb8ac09-8fd2-4cb6-bad0-bc4f9b48a708
    Associated GPIs 62053550100320
    GCN Sequence Number 053324
    GCN Sequence Number Description memantine HCl TABLET 5 MG ORAL
    HIC3 H1A
    HIC3 Description ALZHEIMER'S THERAPY, NMDA RECEPTOR ANTAGONISTS
    GCN 20773
    HICL Sequence Number 013778
    HICL Sequence Number Description MEMANTINE HCL
    Brand/Generic Brand
    Proprietary Name Namenda
    Proprietary Name Suffix n/a
    Non-Proprietary Name memantine hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name MEMANTINE HYDROCHLORIDE
    Labeler Name Allergan, Inc.
    Pharmaceutical Class N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA021487
    Listing Certified Through 2024-12-31

    Package

    NDC 00456-3205-60 (00456320560)

    NDC Package Code 0456-3205-60
    Billing NDC 00456320560
    Package 60 TABLET in 1 BOTTLE (0456-3205-60)
    Marketing Start Date 2003-10-16
    NDC Exclude Flag N
    Pricing Information N/A